Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of Resistance in Preclinical Models

Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models